BioCentury
ARTICLE | Clinical News

Celgosivir: Phase II start

July 24, 2006 7:00 AM UTC

This month, MGI will start a Canadian Phase II trial in up to 20 treatment-naïve HCV patients. The trial will compare celgosivir plus peginterferon alfa-2b and ribavirin with peginterferon alfa-2b and...